BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 454536)

  • 21. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis of derivatives of N-(1-adamantyl)-N'-urea with potential antiviral activity].
    Skwarski D; Maliszewska H
    Acta Pol Pharm; 1988; 45(5):391-4. PubMed ID: 3247849
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiviral agents. 2. Structure-activity relationships of compounds related to 1-adamantanamine.
    Aldrich PE; Hermann EC; Meier WE; Paulshock M; Prichard WW; Snyder JA; Watts JC
    J Med Chem; 1971 Jun; 14(6):535-43. PubMed ID: 5091970
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and antiviral activities of adamantane spiro compounds. 1. Adamantane and analogous spiro-3'-pyrrolidines.
    Lundahl K; Schut J; Schlatmann JL; Paerels GB; Peters A
    J Med Chem; 1972 Feb; 15(2):129-32. PubMed ID: 4332673
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and antiviral activities of adamantane spiro compounds. 2.
    Smit A; Kralt T; Peters A; van Hes R
    J Med Chem; 1972 Feb; 15(2):132-6. PubMed ID: 5008237
    [No Abstract]   [Full Text] [Related]  

  • 26. Adamantylthiourea derivatives as antiviral agents.
    Tilley JW; Levitan P; Kramer MJ
    J Med Chem; 1979 Aug; 22(8):1009-10. PubMed ID: 490532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [1-Adamanty fluoroformate, a useful reagent in peptide chemistry (author's transl)].
    Moroder L; Wackerle L; Wünsch E
    Hoppe Seylers Z Physiol Chem; 1976 Nov; 357(11):1647-50. PubMed ID: 1002131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
    Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
    Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, X-ray crystal structure study, and cytostatic and antiviral evaluation of the novel cycloalkyl-N-aryl-hydroxamic acids.
    Barbarić M; Ursić S; Pilepić V; Zorc B; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; Snoeck R; Andrei G; Balzarini J; De Clercq E; Mintas M
    J Med Chem; 2005 Feb; 48(3):884-7. PubMed ID: 15689173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
    Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Compounds with potential antitumor activity. II. N,N'-(1-Diadamantandicarboxyamides)].
    Ficarra P; Ficarra R; Tommasini A; Fenech G
    Farmaco Sci; 1983 Jun; 38(6):418-24. PubMed ID: 6873275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologically active polycycloalkanes. 2. Antiviral 4-homoisotwistane derivatives.
    Aigami K; Inamoto Y; Takaishi N; Fujikura Y
    J Med Chem; 1976 Apr; 19(4):536-40. PubMed ID: 1263206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral agents. I. Bicyclo [2.2.2] octan- and -oct-2-enamines.
    Whitney JG; Gregory WA; Kauer JC; Roland JR; Snyder JA; Benson RE; Hermann EC
    J Med Chem; 1970 Mar; 13(2):254-60. PubMed ID: 5418498
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antiviral agents. 24. 4(-2-Adamantyl)thiosemicarbazone].
    Kreutzberger A; Schröders HH; Stratmann J
    Arch Pharm (Weinheim); 1984 Sep; 317(9):767-71. PubMed ID: 6508510
    [No Abstract]   [Full Text] [Related]  

  • 35. Exceedingly Efficient Synthesis of (±)-Grandifloracin and Acylated Analogues.
    Bergner M; Duquette DC; Chio L; Stoltz BM
    Org Lett; 2015 Jun; 17(12):3008-10. PubMed ID: 26060887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The benzo-1,2,3-triazine ring system as basis of potentially virustatic compounds (author's transl)].
    Kreutzberger A; Schröders HH
    Arch Pharm (Weinheim); 1975 Mar; 308(3):161-9. PubMed ID: 1130953
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis, antifungal, antibacterial and antiviral effects of some adamantaneketoxime ethers.
    Papadaki-Valiraki A; Papakonstantinou-Garoufalias S; Marakos P; Chytyroglou-Lada A; Hosoya M; Balzarini J; de Clercq E
    Farmaco; 1993 Aug; 48(8):1091-102. PubMed ID: 8216671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antiviral evaluation of bisnoradamantane sulfites and related compounds.
    Valverde E; Torres E; Guardiola S; Naesens L; Vázquez S
    Med Chem; 2011 Mar; 7(2):135-9. PubMed ID: 21222614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiviral agents / 9th communication: virustatically active N-(1-adamantyl)-thiourea derivatives based on cyclic secondary amines (author's transl)].
    Kreutzberger A; Schröders HH
    Arzneimittelforschung; 1977; 27(5):969-72. PubMed ID: 577881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicinal properties of adamantane derivatives.
    Wishnok JS
    J Chem Educ; 1973 Nov; 50(11):780-9. PubMed ID: 4747926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.